AJAY BANSAL Insider Trading
Get free email notifications about insider trading for AJAY BANSAL.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of AJAY BANSAL. AJAY BANSAL is a in NEKTAR THERAPEUTICS ($NKTR) and a CFO, VP Finance & Admin in NEKTAR THERAPEUTICS ($NKTR) and a Chief Financial Officer in Onconova Therapeutics, Inc. ($ONTX) and a Chief Financial Officer in ViewRay, Inc. ($VRAY) and a PFO;CFO/Urovant Sciences, Inc. in Urovant Sciences Ltd. ($UROV).
Address: 150 INDUSTRIAL ROAD SAN CARLOS 94070 CA
Companies in which AJAY BANSAL is an Insider
NEKTAR THERAPEUTICS
Trading Symbol: NKTRIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of AJAY BANSAL:
Holdings: 10,333 shares
Current Value: $136,086
Latest Transaction: Mar 13 2006
$NKTR Market Capitalization: $2.01B
$NKTR Previous Close: $13.17
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Onconova Therapeutics, Inc.
Trading Symbol: ONTXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of AJAY BANSAL: Chief Financial Officer
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jan 28 2016
$ONTX Market Capitalization: $18.13M
$ONTX Previous Close: $2.68
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Urovant Sciences Ltd.
Trading Symbol: UROVIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of AJAY BANSAL: PFO;CFO/Urovant Sciences, Inc.
Holdings: 138,659 shares
Latest Transaction: May 04 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ViewRay, Inc.
Trading Symbol: VRAYIndustry: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
Position of AJAY BANSAL: Chief Financial Officer
Holdings: 103,284 shares
Current Value: $614,540
Latest Transaction: Jul 29 2019
$VRAY Market Capitalization: $257.35M
$VRAY Previous Close: $5.95
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of AJAY BANSAL
Sentiment: All, NKTR, ONTX, UROV, VRAY
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 04 2020 | UROV | Urovant Sciences L ... | BANSAL AJAY | PFO;CFO/Urovant Sci ... | Grant | A | 0.00 | 63,659 | 0 | 138,659 | 75 K to 138.7 K (+84.88 %) |
Nov 05 2019 | UROV | Urovant Sciences L ... | BANSAL AJAY | PFO;CFO/Urovant Sci ... | Option Exercise | A | 9.66 | 140,000 | 1,352,400 | 140,000 | |
Nov 05 2019 | UROV | Urovant Sciences L ... | BANSAL AJAY | PFO;CFO/Urovant Sci ... | Grant | A | 0.00 | 75,000 | 0 | 75,000 | 0 to 75 K |
Jul 29 2019 | VRAY | ViewRay, Inc. | BANSAL AJAY | Chief Financial Off ... | Option Exercise | X | 3.17 | 12,519 | 39,685 | 0 | |
Jul 29 2019 | VRAY | ViewRay, Inc. | BANSAL AJAY | Chief Financial Off ... | Payment of Exercise | F | 9.00 | 4,408 | 39,672 | 98,876 | 103.3 K to 98.9 K (-4.27 %) |
Jul 29 2019 | VRAY | ViewRay, Inc. | BANSAL AJAY | Chief Financial Off ... | Buy | X | 3.17 | 12,519 | 39,685 | 103,284 | 90.8 K to 103.3 K (+13.79 %) |
Mar 05 2019 | VRAY | ViewRay, Inc. | BANSAL AJAY | Chief Financial Off ... | Option Exercise | A | 8.47 | 36,038 | 305,242 | 36,038 |